Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy

by Andreatta, M., Barras, D., Benedetti, F., Berthold, D.R, Bourhis, J., Carmona, S.J, Corria-Osorio, J., Coukos, G., Crespo, I., Dafni, U., de Olza, M.O, Dimopoulou, G., Dromain, C., Duran, R., Foukas, P., Genolet, R., Ghisoni, E., Harari, A., Herrera, F.G, Imbimbo, M., Irving, M., Kandalaft, L.E, Laniti, D.D, Messemaker, M., Orcurto, A., Pittet, M.J, Prior, J., Rodrigo, B.N, Ronet, C., Rusakiewicz, S., Sarivalasis, A., Schaefer, N., Sempoux, C., Smith, T., Spill, A., Tsourti, Z., Warren, S.E, Zaman, K., Zimmermann, S.
Published 2022

Peanut oral immunotherapy differentially suppresses clonally distinct subsets of T helper cells

by Christopher Love, J., Gierahn, T.M, Ginder, J.H, Monian, B., Morgan, D.M, Petrossian, P.M, Ruiter, B., Shreffler, W.G, Smith, N.P, Tu, A.A
Published 2022

Characterization of the immune response in patients with cancer of the oral cavity after neoadjuvant immunotherapy with the IRX-2 regimen

by Bellile, E., Bryan Bell, R., Campos, C.Z, Cernea, C.R, Cruz, F.J.S.M, D'Silva, N., Erman, A., Girotto, G.C, Higgins, K., Kaplan, M., Kraus, D., Krempl, G., Liu, S., Martins, W.A, McCaul, J., Moyer, J., Newman, J., Nguyen, A., Nieva, J., Oliveira, F., Panwar, A., Patel, M., Rozek, L., Sartor, M.A, the INSPIRE Trial Clinical Investigators, Valentino, J., Victorina, A.P, Wolf, G.T, Zarins, K.
Published 2021

HIF activation enhances FcγRIIb expression on mononuclear phagocytes impeding tumor targeting antibody immunotherapy

by Beers, S.A, Booth, S.G, Carter, M.J, Chee, S.J, Cleary, K.L.S, Cragg, M.S, Cutress, R.I, Dahal, L.N, Douglas, J., Foxall, R.B, French, R.R, Frendéus, B., Ghorbani, M., Glennie, M.J, Hargreaves, C.E, Hussain, K., James, S., Kemp, R.S, Liu, R., Longley, J., Macari, S., Markham, H., Müller, K.T.J, Murray, T., Oldham, R.J, Ottensmeier, C.H, Roghanian, A., Smith, R.C.G, Stopforth, R.J, Strefford, J.C, Thirdborough, S.M
Published 2022

Systemic high-dose dexamethasone treatment may modulate the efficacy of intratumoral viral oncolytic immunotherapy in glioblastoma models

by Aguilar, E., Aguilar, L.K, Barone, F., Chiocca, E.A, Griffith, A.M, Guzik, B.W, Koch, M.S, Lawler, S., Lederer, J.A, Nowicki, M.O, Tabatabai, G., Tak, P.P, Zdioruk, M.
Published 2022

Dysregulated ferroptosis-related genes indicate potential clinical benefits for anti–PD-1/PD-L1 immunotherapy in lung adenocarcinoma

by Chen, Y., Li, T., Zhang, X., Zhou, M.
Published 2021

A mutation-based gene set predicts survival benefit after immunotherapy across multiple cancers and reveals the immune response landscape

by Bian, J., Chen, P., Lin, Y., Long, J., Sang, X., Wang, A., Wang, D., Yang, X., Zhang, H., Zhao, H., Zheng, M., Zheng, Y.
Published 2022

Real-world evidence for option value in metastatic melanoma

by Garrison, L.P., Jr, Lee, W., Li, M., To, T.M, Veenstra, D.L, Wong, W.B
Published 2021

ISOTOPE: ISOform-guided prediction of epiTOPEs in cancer

by Eyras, E., Fugmann, T., Pérez-Granado, J., Reixachs-Solé, M., Sanz, F., Trincado, J.L, Yokota, J.
Published 2021

Mathematical model of a personalized neoantigen cancer vaccine and the human immune system

by McGill, J.R, Messan, M.R, Nukala, U., Sauna, Z.E, Yang, H., Yogurtcu, O.N
Published 2021

A novel functional mast cell assay for the detection of allergies

by Bachmann, D., Brigger, D., Eggel, A., Helbling, A., Hoffmann, H.J, Horn, M.P, Jörg, L., Kaufmann, T., Kinet, J.-P, Schmid, J.M, Zbären, N.
Published 2022

Human mesenchymal stem cells inhibit the differentiation and effector functions of monocytes

by Algraittee, S.J.R, Boroojerdi, M.H, John, C.M, Maqbool, M., Ramasamy, R., Sarmadi, V.H, Vidyadaran, S.
Published 2019

Utilizing the nanosecond pulse technique to improve antigen intracellular delivery and presentation to treat tongue squamous cell carcinoma

by Chen, J., Gao, C., Liu, Y., Wang, J., Zhang, J., Zhang, X., Zhao, J.
Published 2018

Characterization and Functional Analysis of Tumor-Derived Microparticles

by Huang, B., Ma, J., Tang, K., Wei, K., Zhang, H.
Published 2021

Soluble PD-L1 as an early marker of progressive disease on nivolumab

by Choueiri, T.K, Freeman, G.J, Mahoney, K.M, Mcdermott, D.F, Ross-Macdonald, P., Song, L., Stephen Hodi, F., Veras, E., Wind-Rotolo, M., Yuan, L.
Published 2022

G6PD functions as a metabolic checkpoint to regulate granzyme B expression in tumor-specific cytotoxic T lymphocytes

by Colby, A.H, Colson, Y.L, Ding, H.-F, Grinstaff, M.W, Klement, J.D, Liu, K., Lu, C., Oberlies, N.H, Pearce, C.J, Shi, H., Yang, D.
Published 2022

Influence of tumor mutational burden, inflammatory gene expression profile, and PD-L1 expression on response to pembrolizumab in head and neck squamous cell carcinoma

by Albright, A., Ayers, M., Burtness, B., Cheng, J., Chow, L.Q.M, Cristescu, R., Eder, J.P, Gluck, I., Gupta, S., Haddad, R.I, Huang, L., Kang, H., Keam, B., Lunceford, J., Mehra, R., Mogg, R., Muro, K., Seiwert, T.Y, Tahara, M., Weiss, J.
Published 2022

Sinonasal mucosal melanoma extended to nose bridge: A one-time reconstruction treatment report

by Abbate, V., Califano, L., Cieri, M., Dell'Aversana Orabona, G., Iaconetta, G., Mascolo, M., Pansini, A., Romano, A., Salzano, G.
Published 2018

Tisagenlecleucel outcomes in relapsed/refractory extramedullary ALL: A Pediatric Real World CAR Consortium Report

by Baggott, C., Brown, P.A, Chinnabhandar, V., Curran, K.J, Egeler, E., Fabrizio, V.A, Hermiston, M., Karras, N.A, Keating, A.K, Krupski, C., Kunicki, M., Laetsch, T.W, Lane, A., Mackall, C.L, Margossian, S.P, Mavroukakis, S., Moskop, A., Myers, G.D, Pacenta, H., Phillips, C.L, Prabhu, S., Qayed, M., Rabik, C.A, Rossoff, J., Satwani, P., Schultz, L.M, Stefanski, H.E, Talano, J.-A, Verneris, M.R, Wilcox, R., Yasemin Goksenin, A.
Published 2022

Clinical evaluation of a laboratory-developed test using clone E1L3N for the detection of PD-L1 expression status in non-small cell lung cancer

by Chen, C., Chen, G., Dong, X., Hou, T., Li, Y., Xu, H., Ye, J., Zhao, H.
Published 2021